We Know How to Develop

Upscaling Biologics for Bio Needs


With top-notch facilities and a well-experienced team, we are all set to enter the biopharmaceutical sector and provide biological medicines to metabolic disorders, inflammatory disease and various forms of cancer.

Procell Biologics, established in 2021, is a new scientific player in the pharmaceutical industry engaged in research & development, manufacturing and marketing of therapeutic drugs across various segments. We are well-equipped with top-notch facilities and have built capabilities for Biosimilar Development and services for Biotherapeutic Development. We also strive to extend our services to CDMO activities by the end of the year 2022.

what we do

From a Vial to Finished Product

We have a dedicated team of experts from the pharmaceutical and biologics industry who work hard for providing up-to-date products. Their efforts result in manufacturing well-researched and tested range of biologics for the mankind across globe.

Generic products

Biosimilar section

R&D department

Development wing

Contract Research (CR) Services